LMR Partners LLP

Position in MRNA — Moderna, Inc.

CIK 1578621 LONDON, X0

Back to MRNA Full portfolio

Position in MRNA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$35,509

-$3,024,579 QoQ

Shares Held

699

-99.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

18 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in MRNA Over Time

Shares Held

Position Value (USD)

Derivatives in MRNA

reported options exposure · as of Mar 31, 2026

CallValue

$14,732,000

CallShares

290,000

PutValue

$42,859,960

PutShares

843,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

LMR Partners LLP holds $224,816,570 across 60 Biotechnology names. MRNA ranks #52 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	74,661	$24,703,084
2	ACLX	Arcellx, Inc.	212,495	$24,398,675
3	TERN	Terns Pharmaceuticals, Inc.	400,000	$21,088,000
4	BMRN	Biomarin Pharmaceutical Inc	324,939	$18,355,804
5	ARGX	Argenx SE	23,488	$17,152,112
6	APLS	Apellis Pharmaceuticals, Inc.	403,622	$16,237,713
7	FOLD	AMICUS THERAPEUTICS, INC.	1,049,700	$15,178,662
8	RVMD	Revolution Medicines, Inc.	130,000	$12,642,500

All Filings in MRNA

Export CSV

36 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$42,859,960	843,700	+120601.0%	Put	Sole	2026-05-15
2026-03-31	$35,509	699	-99.8%	Shares	Sole	2026-05-15
2026-03-31	$14,732,000	290,000	-58.5%	Call	Sole	2026-05-15
2025-12-31	$20,622,357	699,300	+573.9%	Put	Sole	2026-02-17
2025-12-31	$3,060,088	103,767	-50.7%	Shares	Sole	2026-02-17
2025-12-31	$6,210,594	210,600	+541.9%	Call	Sole	2026-02-17
2025-09-30	$847,456	32,809	-94.4%	Shares	Sole	2025-11-14
2025-09-30	$15,255,198	590,600	+37.2%	Put	Sole	2025-11-14
2025-09-30	$11,122,398	430,600	+761.2%	Call	Sole	2025-11-14
2025-06-30	$1,379,500	50,000	-5.2%	Call	Sole	2025-08-14
2025-06-30	$1,455,454	52,753	+2.6%	Shares	Sole	2025-08-14
2025-06-30	$1,418,126	51,400	-43.0%	Put	Sole	2025-08-14
2025-03-31	$2,557,170	90,200	+691.2%	Call	Sole	2025-05-15
2025-03-31	$323,190	11,400	-83.8%	Shares	Sole	2025-05-15
2025-03-31	$1,990,170	70,200	+234.3%	Put	Sole	2025-05-15
2024-12-31	$873,180	21,000	-75.3%	Call	Sole	2025-02-14
2024-12-31	$3,534,300	85,000	-93.6%	Put	Sole	2025-02-14
2024-09-30	$88,543,067	1,324,900	+278.4%	Put	Sole	2024-11-07
2024-09-30	$23,399,388	350,133	+203.1%	Shares	Sole	2024-11-07
2024-09-30	$7,718,865	115,500	+114.3%	Call	Sole	2024-11-07
2024-06-30	$6,400,743	53,901	-81.8%	Shares	Other	2024-08-14
2024-06-30	$35,150,000	296,000	-5.2%	Put	Other	2024-08-14
2024-06-30	$37,061,875	312,100	+680.2%	Call	Other	2024-08-14
2024-03-31	$4,262,400	40,000	+100.0%	Call	Sole	2024-05-15
2024-03-31	$2,131,200	20,000	+100.0%	Put	Sole	2024-05-15
2023-12-31	$994,500	10,000	-88.9%	Call	Sole	2024-02-14
2023-12-31	$8,950,500	90,000	+157.1%	Put	Sole	2024-02-14
2023-09-30	$3,615,150	35,000	-76.1%	Call	Sole	2023-11-14
2023-09-30	$15,131,985	146,500	+14.4%	Put	Sole	2023-11-14
2023-06-30	$15,564,150	128,100	-88.9%	Put	Sole	2023-08-14
2023-03-31	$177,738,134	1,157,300	+2424.4%	Call	Sole	2023-05-15
2022-06-30	$6,548,815	45,844	-40.7%	Shares	Sole	2022-08-15
2022-03-31	$13,316,214	77,303	+120.2%	Shares	Sole	2022-05-16
2021-03-31	$4,596,345	35,100	-68.4%	Shares	Sole	2021-05-17
2020-12-31	$11,606,199	111,096	-64.1%	Shares	Sole	2021-02-16
2020-09-30	$21,921,321	309,842	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.